Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Completed4

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT03142763Not ApplicableCompleted
Assessment of TMAO Formation With Egg Intake Versus Choline Supplement in a Healthy Population
Cardiovascular Risk Factor
PrincipalinvestigatorStart date: 2017-01-01
NCT02531958Not ApplicableCompleted
Assessment of Optimal Egg Intake in a Healthy Population
Cardiovascular Disease
PrincipalinvestigatorStart date: 2015-08-14
NCT01010841Not ApplicableCompleted
Trial of Two Dietary Programs on Cardiometabolic Risk Factors in Subjects With Metabolic Syndrome
HypercholesterolemiaMetabolic SyndromeObesity+1 more
Principalinvestigator
NCT02531334Not ApplicableCompleted
Effects of TA-65, a Telomerase Activator on Metabolic Syndrome
Metabolic Syndrome X
Principalinvestigator

Research Network

Collaboration Network

4 collaborators·6 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Robert H Lerman, MD/PhD

MetaProteomics LLC

Moderately Similar
1 trials

Shared therapeutic areas:

HypercholesterolemiaMetabolic SyndromeObesity+1 more

Worked with same sponsors:

MetaProteomics LLCUniversity of California, Irvine+2 more
Collaborated on 1 trial
Similarity Score44%

Mark McIntosh, MD

University of Florida

Moderately Similar
1 trials

Shared therapeutic areas:

HypercholesterolemiaMetabolic SyndromeObesity+1 more

Worked with same sponsors:

MetaProteomics LLCUniversity of California, Irvine+2 more
Collaborated on 1 trial
Similarity Score44%

Wadie Najm, PhD

University of California at Irvine

Moderately Similar
1 trials

Shared therapeutic areas:

HypercholesterolemiaMetabolic SyndromeObesity+1 more

Worked with same sponsors:

MetaProteomics LLCUniversity of California, Irvine+2 more
Collaborated on 1 trial
Similarity Score44%

Zhaoping Li, MD, PhD

University of California, Los Angeles

Related
17 trials

Shared therapeutic areas:

Cardiovascular DiseasesHypercholesterolemiaObesity+1 more
Similarity Score20%

David s Ludwig, MD, PhD

Boston Children's Hospital

Related
17 trials

Shared therapeutic areas:

ObesityCardiovascular DiseasesOverweight+1 more
Similarity Score20%

David Crowley, MD

KGK Science Inc.

Related
54 trials

Shared therapeutic areas:

OverweightHypercholesterolemiaMetabolic Syndrome+1 more
Similarity Score20%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

ObesityMetabolic Syndrome
Similarity Score10%

David Meeker, MD

Rhythm Pharmaceuticals, Inc.

Related
19 trials

Shared therapeutic areas:

ObesityOverweight
Similarity Score10%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

HypercholesterolemiaObesity
Similarity Score10%

Jack A Yanovski, M.D.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Related
23 trials

Shared therapeutic areas:

ObesityOverweight
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT03142763Not ApplicablePrincipalInvestigator

Assessment of TMAO Formation With Egg Intake Versus Choline Supplement in a Healthy Population

Cardiovascular Risk Factor
Completed
NCT02531958Not ApplicablePrincipalInvestigator

Assessment of Optimal Egg Intake in a Healthy Population

Cardiovascular Disease
Completed
NCT01010841Not ApplicablePrincipalInvestigator

Trial of Two Dietary Programs on Cardiometabolic Risk Factors in Subjects With Metabolic Syndrome

HypercholesterolemiaMetabolic SyndromeObesity+1 more
Completed
NCT02531334Not ApplicablePrincipalInvestigator

Effects of TA-65, a Telomerase Activator on Metabolic Syndrome

Metabolic Syndrome X
Completed

All 4 trials loaded